12 days ago
Any suggestion from the denialists that Skinbiotherapeutics (SBTX) might have over egged the extent of the crimes of disgraced prolific liar and fraudster Stuart Ashman and that there might be a kiss and make up are today put to bed with news that Rachel Parsonage has been appointed as interim CEO. She appears to have a cracking CV but..
16 days ago
It is not a major thing but it raises two issues. On 5th December in an RNS Skinbiotherapeutics (SBTX) promised that its shareholders could quiz the company in an Investor Meet (IMC) session in January. Now Stuart Ashman might, as is his wont, accuse me of being a prolific liar in stating this but you can check out the announcement and I am telling the truth. As for Ashman…
28 days ago
The failure of SkinBiotherapeutics (SBTX) to say why Stuart Ashman had been suspended before he resigned as CEO means that there can be no certainty as to the financial position of the company or the veracity of past claims made by Ashman and, as such, anyone buying shares is terribly brave. They may be rewarded they may not be, we shall see. But in thus void there are some crazy theories doing the rounds. A lawyer writes.
92 days ago
I consider today's developments at Versarien (VRS) whose former CEO repeatedly accused me of lying, Skinbiotherapeutics (SBTX) whose CEO's homework has just been marked as a fail by Sam Antar and Nightcap (NGHT) and all the red flags flying today.
92 days ago
The audio clip below is from an interview conducted by a small furry rodent and Stuart Ashman the CEO at Skinbiotherapeutics (SBTX). Natch the defamatory statement is not corrected or challenged by the rodent.
